All these observations derive from controlled trials on the drug candidates and describe only findings within the trial context, not experiences from use outside research
Acknowledging strengths and limitations of current evidence, the review underscores the necessity for longitudinal studies
Vitamin B Shots and Weight Loss: Separating Fact from Fiction While some studies suggest a correlation between higher B12 levels and reduced obesity risk, this does not imply causation
This discovery led to the development of exenatide, which in 2005 became the first GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes (T2DM)
[DOI] [PubMed] [Google Scholar] 151.Mhamdi A., Queval G., Chaouch S., Vanderauwera S., van Breusegem F., Noctor G